2025 annual financial data
Outlook Therapeutics 2025 Net margin
Direct answer
Net margin was -4,416.22%.
Operating income was -67,061,666 USD and net income was -62,424,863 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,413,535 USD
- Operating income
- -67,061,666 USD
- Net income
- -62,424,863 USD
- Operating cash flow
- Not available
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Outlook Therapeutics financial years